| Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA … P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ... European journal of heart failure 22 (8), 1378-1389, 2020 | 110 | 2020 |
| Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ... European journal of heart failure 22 (1), 92-102, 2020 | 90 | 2020 |
| A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC‐HFA EORP Heart Failure Long … A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ... European Journal of Heart Failure 24 (2), 335-350, 2022 | 60 | 2022 |
| Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC‐EORP Heart Failure Long‐Term Registry CJ Kapelios, C Laroche, MG Crespo‐Leiro, SD Anker, AJS Coats, ... European journal of heart failure 22 (8), 1424-1437, 2020 | 47 | 2020 |
| Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure Y Cavusoğlu, KU Mert, A Nadir, F Mutlu, E Gencer, T Ulus, A Birdane, ... Eur J Heart Fail, Supp, 2012 | 41 | 2012 |
| Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study Y Çavuşoğlu, S Korkmaz, S Demirtaş, E Gencer, H Sasmaz, F Mutlu, ... Journal of the American College of Cardiology 62 (18_S2), İkincilik Ödülü …, 2013 | 18 | 2013 |
| Post-discharge heart failure monitoring program in Turkey: Hit-PoinT Y Çavuşoğlu, M Zoghi, M Eren, E Bozçalı, G Kozdağ, T Şentürk, G Alicik, ... Anatolian journal of cardiology 17 (2), 107, 2017 | 16 | 2017 |
| Comparison of the effects of levosimendan dobutamine and vasodilator therapy on ongoing myocardial injury in acute decompensated heart failure E Gencer, V Doğan, MT Öztürk, A Nadir, A Musmul, Y Cavuşoğlu Journal of cardiovascular pharmacology and therapeutics 22 (2), 153-158, 2017 | 9 | 2017 |
| Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in‐hospital and long‐term outcomes–from the ESC‐HFA EORP Heart … A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ... European Journal of Heart Failure 25 (9), 1571-1583, 2023 | 5 | 2023 |
| Post-discharge heart failure monitoring program in Turkey: Hit-PoinT Y Çavusoglu, M Zoghi, M Eren, E Bozcali, G Kozdag, T Sentürk, G Alicik, ... The Anatolian Journal of Cardiology 17 (2), 107, 2017 | 5 | 2017 |
| Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the … M Kayıkcioglu, Ö Başaran, V Doğan, KU Mert, GÖ Mert, İH Özdemir, ... Journal of Clinical Lipidology 17 (6), 732-742, 2023 | 2 | 2023 |
| Dobutamine-induced increase in heart rate is blunted by ivabradine treatment in patients with acutely decompensated heart failure Y Cavusoglu, KU Mert, A Nadir, F Mutlu, E Gencer, T Ulus, A Birdane European Heart Journal 33, 8-8, 2012 | 2 | 2012 |
| How Did the Updated 2019 European Society of Cardiology/European Atherosclerosis Society Risk Categorization for Patients with Diabetes Affect the Risk Perception and Lipid … Ö Başaran, V Doğan, KU Mert, B Özlek, E Özlek, O Çelik, C Çil, ... Anatolian journal of cardiology 27 (2), 78, 2023 | 1 | 2023 |
| Consistency of Friedewald, Martin/Hopkins and Samson formulas for LDL-C calculation in high and very high cardiovascular risk patients O Basaran, V Dogan, O Celik, C Cil, B Ozlek, E Ozlek, IH Ozdemir, ... Atherosclerosis 355, 78, 2022 | | 2022 |
| Serial changes and associated clinical variables of cardiac troponin release in patients with acute heart failure syndrome Y Cavusoglu, E Gencer, S Eraslan, F Mutlu, B Morrad Eur J Heart Fail 18 (PP: 412), s: 100, 2016 | | 2016 |
| Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes Y Cavusoglu, E Gencer, F Mutlu, A Nadir, KU Mert, B Morrad, S Eraslan European Journal of Heart Failure 16, 159-160, 2014 | | 2014 |
| Levosimendan akut kalp yetersizliğinde dobutamine göre renoprotektif potansiyel sergilemektedir. Y Çavuşoğlu, E Gencer, KU Mert, A Nadir, F Mutlu, B Morrad, S Eraslan, ... 30. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 2014 | | 2014 |
| Akut dekompanse kalp yetersizliğinde kardiyak troponin yüksekliği ve ilişkili bulunan klinik değişkenler Y Çavuşoğlu, E Gencer, KU Mert, A Nadir, F Mutlu, S Eraslan, B Morrad, ... 30. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 2014 | | 2014 |
| Ivabradine treatment blunts dobutamine-induced increase in heart rate in patients with acute decompensated heart failure: a comparative study with beta blocker therapy Y Çavuşoğlu, KU Mert, A Nadir, F Mutlu, E Gencer, T Ulus European Journal of Heart Failure 15 (Supp 1), 2013 | | 2013 |
| Effects of levosimendan and dobutamine on systolic time intervals in patients with acute decompensated heart failure Y Cavusoglu, A Nadir, KU Mert, E Gencer, F Mutlu, T Ulus Eur J Heart Fail 15 (Supp 1), 2013 | | 2013 |
